[go: up one dir, main page]

AU5223879A - Cephalosporin compounds - Google Patents

Cephalosporin compounds

Info

Publication number
AU5223879A
AU5223879A AU52238/79A AU5223879A AU5223879A AU 5223879 A AU5223879 A AU 5223879A AU 52238/79 A AU52238/79 A AU 52238/79A AU 5223879 A AU5223879 A AU 5223879A AU 5223879 A AU5223879 A AU 5223879A
Authority
AU
Australia
Prior art keywords
cephalosporin compounds
cephalosporin
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU52238/79A
Other versions
AU529823B2 (en
Inventor
Barry Edward Ayres
David George Hubert Livermore
Christopher Earle Newall
Cynthia Hilda O:callaghan
Derek Ronald Sutherland
Niall Galbraith Weir
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU5223879A publication Critical patent/AU5223879A/en
Application granted granted Critical
Publication of AU529823B2 publication Critical patent/AU529823B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU52238/79A 1978-10-26 1979-10-26 Cephalosporin compounds Ceased AU529823B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4216278 1978-10-26
GB7842162 1978-10-27

Publications (2)

Publication Number Publication Date
AU5223879A true AU5223879A (en) 1980-05-01
AU529823B2 AU529823B2 (en) 1983-06-23

Family

ID=10500626

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52238/79A Ceased AU529823B2 (en) 1978-10-26 1979-10-26 Cephalosporin compounds

Country Status (4)

Country Link
JP (1) JPS5559196A (en)
AU (1) AU529823B2 (en)
BE (1) BE879664A (en)
ZA (1) ZA795736B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA806977B (en) * 1979-11-19 1981-10-28 Fujisawa Pharmaceutical Co 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4457929A (en) * 1982-03-29 1984-07-03 Bristol-Myers Company 3-Quaternary ammonium methyl)-substituted cephalosporin derivatives

Also Published As

Publication number Publication date
ZA795736B (en) 1980-10-29
JPS5559196A (en) 1980-05-02
AU529823B2 (en) 1983-06-23
BE879664A (en) 1980-04-28

Similar Documents

Publication Publication Date Title
JPS55149289A (en) Cephalosporin compound
AU526954B2 (en) Penicillin composition
AU528675B2 (en) Cephalosporin analogs
AU529330B2 (en) Piperazinylbenzoheterocyclic compounds
GB2036724B (en) Cephalosporin compounds
AU526183B2 (en) Sulfonato-organosilanol compounds
AU4690979A (en) Heterocyclic compounds
AU528403B2 (en) Flukicidal compounds
AU525132B2 (en) Beta-lactam compounds
AU4808579A (en) Cephalosporin analogs
AU529031B2 (en) Cephalosporin composition
ZA791653B (en) Cephalosporin compounds
AU527128B2 (en) Cephalosporin analogs
AU529338B2 (en) Cephalosporin compounds
GB2018764B (en) Cephalosporin compounds
AU520081B2 (en) Furonaphthyridine compounds
AU529823B2 (en) Cephalosporin compounds
AU524816B2 (en) Cephalosporin derivatives
AU6235580A (en) Cephalosporin analogs
AU534617B2 (en) Cephalosporin compounds
AU531535B2 (en) Oxothia compounds
AU5068579A (en) Compounds
AU4894579A (en) 1-isocyano-1-sulphonylalkenyl compounds
AU515733B2 (en) Cephalosporins
AU524230C (en) Cephalosporin derivatives